ASMB vs XYL · rev $21.6M vs P/E 27, rev $4.46B
Assembly Biosciences Inc (ASMB) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
ASMB currently screens at market cap $143.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the ASMB and XYL stock pages for the full models.
Not investment advice.